Invention Grant
- Patent Title: Gene editing components, systems, and methods of use
-
Application No.: US18481393Application Date: 2023-10-05
-
Publication No.: US12264328B2Publication Date: 2025-04-01
- Inventor: Giedrius Gasiunas , Alim Ladha , Vladimir Presnyak , Muthusamy Jayaraman , Elisabeth Narayanan
- Applicant: ReNAgade Therapeutics Management Inc.
- Applicant Address: US MA Cambridge
- Assignee: ReNAgade Therapeutics Management Inc.
- Current Assignee: ReNAgade Therapeutics Management Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Duane Morris LLP
- Agent Thomas J. Kowalski
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N9/22 ; C12N15/86
Abstract:
The present disclosure provides methods and compositions comprising Cas TypeV programmable nucleases and lipid nanoparticles capable of delivering the Cas TypeV programmable nucleases and genome editing systems comprising same.
Public/Granted literature
- US20240141382A1 GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE Public/Granted day:2024-05-02
Information query
IPC分类:
